Detalhe da pesquisa
1.
Broadly neutralizing antibodies target a haemagglutinin anchor epitope.
Nature
; 602(7896): 314-320, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942633
2.
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
Proc Natl Acad Sci U S A
; 119(45): e2206333119, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322769
3.
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
J Virol
; 97(10): e0105723, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800945
4.
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
J Virol
; 96(2): e0142121, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669506
5.
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
bioRxiv
; 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36299418
6.
Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model.
mSphere
; 7(5): e0092721, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069438
7.
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses.
Nat Commun
; 13(1): 4677, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945226
8.
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Nat Commun
; 13(1): 7864, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543789